Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The investigators will conduct randomized and controlled clinical studies in order to preliminarily explore the efficacy and safety of low-dose cyclophosphamide and lenalidomide in maintenance therapy for MM that is not suitable for transplantation in the standard-risk group.
Epistemonikos ID: 0901268c698eea43d96ed41796a6719a05646998
First added on: May 15, 2024